Dr. Richardson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 University Ave E
Saint Paul, MN 55101Phone+1 651-290-8707
Summary
- Dr. Richardson is a neuromuscular neurologist both board-certified in neuromuscular medicine and neurology with special certification in child neurology. He takes care of adults and children with genetic disorders of the peripheral nervous system across the lifespan is is avidly interested in providing patients access to genetic therapies. He acts as the Gillette Muscular Dystrophy Association Clinic director and serves on the Minnesota Newborn Screen Advisory Committee. He created the Gillette Nusinersen Administration Program, which specializes in providing intrathecal therapies to dozens of patients with spinal muscular atrophy and Niemann-Pick type C via conventional lumbar punctures, fluoroscopic lumbar punctures, or via lumbar subcutaneous reservoirs via a wide range of sedations (no, minimal, moderate, and deep), including those with complex spines. He is hoping to expand intrathecal therapies to other diseases as these treatments are approved. Currently, he is engaged in research in SMA and Duchenne muscular dystrophy, often embracing expanded/managed access programs for medications pending FDA approval. Community and diversity matters. He is working with the Indian Health Board to afford neurologic services to the Native American community. Additionally, he performs electromyography (EMG) and intraoperative monitoring. He frequently finds himself gardening at night, collecting art, rehabilitating antiques, or devouring science fiction.
Clinical Expertise
- Child neurology, Neuromuscular disease, Electromyography, Lumbar puncture, Gene therapy, Neuromuscular medicine, Intraoperative monitoring, Concierge medicine
Education & Training
- University of WashingtonFellowship, Child Neurology, 2005 - 2008
- University of Nebraska Medical Center College of MedicineResidency, Pediatrics, 2003 - 2005
- The Warren Alpert Medical School of Brown UniversityClass of 2003
Certifications & Licensure
- ND State Medical License 2021 - 2026
- MN State Medical License 2013 - 2025
- SD State Medical License Active through 2025
- WI State Medical License 2021 - 2025
- AK State Medical License 2010 - 2014
- WA State Medical License 2006 - 2014
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Clinical Trials
- A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA). Start of enrollment: 2015 Aug 19
Publications & Presentations
PubMed
- 27 citationsLoss of function mutations in GEMIN5 cause a neurodevelopmental disorder.Sukhleen Kour, Deepa S. Rajan, Tyler R. Fortuna, Eric N. Anderson, Caroline Ward
Nature Communications. 2021-05-07 - 59 citationsSafety and efficacy of nusinersen in spinal muscular atrophy: The EMBRACE study.Gyula Acsadi, Thomas O. Crawford, Wolfgang Müller-Felber, Perry B. Shieh, Randal C. Richardson
Muscle & Nerve. 2021-02-16 - 107 citationsDe Novo Mutations in the Motor Domain of KIF1A Cause Cognitive Impairment, Spastic Paraparesis, Axonal Neuropathy, and Cerebellar AtrophyJae-Ran Lee, Myriam Srour, Doyoun Kim, Fadi F. Hamdan, So Hee Lim
Human Mutation. 2015-01-01
Press Mentions
- Program Offers Rapid Genetic Test for Spinal Muscular Atrophy at No ChargeAugust 22nd, 2019
Committees
- member, Minnesota Newborn Screening Advisory Committee 2023 - Present
- Member, Cure SMA Medical Advisory Board 2014 - 2016
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: